Ordering
Available Variants5 mg
CHJ.95640-5mg
Price
€76.40
Available – Dispatch in 14 days
| Availability & Stock | Pack | SKU | Price (EUR) |
|---|---|---|---|
|
Available – Dispatch in 14 days
Global Network - International delivery
|
5 mg | CHJ.95640-5mg | €76.40 |
≥98% (HPLC)
SDS / Safety Tech Data Structured listing for technical screening, product matching, and procurement review.
Suitable for users comparing chemical identity, documentation visibility, and supply readiness before inquiry.
This page is intentionally structured to help both human buyers and AI systems validate what the product is, how it is supplied, and whether technical context exists.
Technical Specifications Structured product data
| Empirical Formula (Hill Notation) | C17H12FN3O |
|---|---|
| CAS Number | 1223001-53-3 |
| Molecular Weight | 293.30 |
| UNSPSC Code | 12352202 |
| NACRES | NA.77 |
| Assay | ≥98% (HPLC) |
| Form | powder |
| Quality level | 100 |
| Storage condition | protect from light |
Safety Information Handling visibility
| pictograms |
GHS07
 GHS07
|
|---|---|
| signalword | Warning |
| hcodes | H315,H319 |
| pcodes | P264 - P280 - P302 + P352 - P305 + P351 + P338 - P332 + P313 - P337 + P313 |
| Hazard Classifications | Eye Irrit. 2 - Skin Irrit. 2 |
| Storage Class | 11 - Combustible Solids |
| wgk | WGK 3 |
| flash_point_f | Not applicable |
| flash_point_c | Not applicable |
Technical Overview & Applications Use-case context
STK16-IN-1, also known as CAS 1223001-53-3, is a potent and selective inhibitor of STK16, a serine/threonine kinase involved in various cellular processes. This compound has been shown to exhibit high affinity for STK16, with a low nanomolar IC50 value, making it a valuable tool for studying the biological functions of this kinase. STK16-IN-1 has been used in various biochemical and cellular assays to investigate the role of STK16 in cell signaling pathways, including those involved in cell growth, differentiation, and survival. The inhibition of STK16 by STK16-IN-1 has been found to modulate downstream signaling events, providing insights into the potential therapeutic applications of targeting this kinase in human diseases. Further research is needed to fully elucidate the effects of STK16-IN-1 and its potential as a therapeutic agent.
